We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 22 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 40 in the last 12 months.
Auto-generated summary combining US and Korean research and earnings · not investment advice
The analyst consensus for ExxonMobil (XOM) is a 'Buy' rating, with an average target price of $169.91, which is higher than the current price. While many brokerage firms maintain positive ratings, some institutions have maintained a neutral stance or even downgraded their ratings. Overall, the prevailing assessment is that there is upside potential.
Divergence: While a generally positive outlook on XOM prevails among analysts, some institutions maintain a neutral stance or have downgraded their investment opinions, leading to somewhat mixed views.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2026. 05. 27. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 12. | Bernstein | — | Maintain | Outperform → Outperform | — | Bernstein: Outperform |
| 2026. 05. 05. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 05. 05. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 04. 23. | Scotiabank | — | Maintain | Sector Outperform → Sector Outperform | — | Scotiabank: Sector Outperform |
| 2026. 04. 21. | Wolfe Research | — | Downgrade | Outperform → Peer Perform | — | Wolfe Research: Outperform → Peer Perform |
| 2026. 04. 18. | BNP Paribas | — | Upgrade | Underperform → Neutral | — | BNP Paribas: Underperform → Neutral |
| 2026. 04. 17. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 04. 11. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 04. 10. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 04. 10. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 04. 10. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 04. 10. | Jefferies | — | Maintain | Buy → Buy | — | Jefferies: Buy |
| 2026. 04. 09. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 04. 09. | Wolfe Research | — | Maintain | Outperform → Outperform | — | Wolfe Research: Outperform |
| 2026. 04. 03. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 03. 28. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 03. 20. | HSBC | — | Maintain | Hold → Hold | — | HSBC: Hold |
| 2026. 03. 18. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2026. 03. 17. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 03. 13. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 03. 03. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 03. 02. | B of A Securities | — | Maintain | Neutral → Neutral | — | B of A Securities: Neutral |
| 2026. 02. 24. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 02. 03. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 02. 03. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 02. 03. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 02. 03. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 01. 28. | B of A Securities | — | Maintain | Neutral → Neutral | — | B of A Securities: Neutral |
| 2026. 01. 24. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 01. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 01. 08. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 01. 06. | Freedom Broker | — | Downgrade | Hold → Sell | — | Freedom Broker: Hold → Sell |
| 2026. 01. 05. | Bernstein | — | Maintain | Outperform → Outperform | — | Bernstein: Outperform |
| 2025. 12. 13. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2025. 12. 12. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2025. 12. 12. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 12. 11. | B of A Securities | — | Maintain | Neutral → Neutral | — | B of A Securities: Neutral |
| 2025. 12. 11. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |